Personal information

No personal information available

Activities

Employment (3)

Servicio Aragonés de Salud: Zaragoza, Zaragoza, ES

2023-11-01 to present | Técnico en Salud Pública
Employment
Source: Self-asserted source
Edgar Peña-Galo

Servicio Aragonés de Salud: Alcañiz, Teruel, ES

2018-05-22 to 2023-10-31 | Médico de Atención Primaria (Equipo de Atención Primaria)
Employment
Source: Self-asserted source
Edgar Peña-Galo

Centro de investigación en demografía y salud. Universidad Nacional Autónoma de Nicaragua-León.: León, León, NI

2006-02-05 to 2012-02-08 (Epidemiología)
Employment
Source: Self-asserted source
Edgar Peña-Galo

Education and qualifications (4)

University of Oxford: Oxford, GB

2021-05-09 to 2021-05-14 | Prevention Strategies for Non- Communicable Diseases (NCDs) (Online) (Department for Continuing Education)
Education
Source: Self-asserted source
Edgar Peña-Galo

Ministerio de Sanidad, España: Zaragoza, Zaragoza, ES

2014-05-22 to 2018-05-21 | Especialista en Medicina Familiar y Comunitaria (Unidad Multiprofesional de Medicina Familiar y Comunitaria, Sector II, Zaragoza.)
Education
Source: Self-asserted source
Edgar Peña-Galo

University of Umea: Umea, SE

2009-06-09 to 2011-06-11 | MPH (Epidemiology and Global Health)
Education
Source: Self-asserted source
Edgar Peña-Galo

Universidad Nacional Autónoma de Nicaragua-León: León, León, NI

1997-03-03 to 2002-03-16 | Doctor en Medicina y Cirugía (Facultad de Ciencias Médicas)
Education
Source: Self-asserted source
Edgar Peña-Galo

Professional activities (3)

Swedish International Development Cooperation Agency: Stockholm, SE

Scholarship - contract to extension of studies (Research cooperation)
Distinction
Source: Self-asserted source
Edgar Peña-Galo

Bill and Melinda Gates Foundation: WA, WA, US

Contract to formation and research
Invited position
Source: Self-asserted source
Edgar Peña-Galo

Aragón Health Research Institute (IIS Aragón): Zaragoza, Zaragoza, ES

(Department of Digestive Diseases, Miguel Servet University Hospital, Zaragoza, Spain)
Service
Source: Self-asserted source
Edgar Peña-Galo

Funding (5)

A phase III randomized trial of three antibiotic regimens to eradicate Helicobacter pylori

Grant
Bill and Melinda Gates Foundation (WA, WA, US)
Part of GRANT_NUMBER:

43930

Source: Self-asserted source
Edgar Peña-Galo

A phase III randomized trial of three antibiotic regimens to eradicate Helicobacter pylori

Grant
National Institutes of Health (Md., Md., US)
Part of GRANT_NUMBER:

NIH: CA037429

Source: Self-asserted source
Edgar Peña-Galo

A population-based study of prevalence and risk factors of chronic kidney disease in Leon, Nicaragua

Grant
Fogarty International Center (Md., Md., US)
Part of GRANT_NUMBER:

1R03TW008060

Part of GRANT_NUMBER:

T32DK007750

Source: Self-asserted source
Edgar Peña-Galo

Study of functional gastrointestinal disorders in the Nicaraguan population, according to the criteria of Rome II

Grant
Rome Foundation (NC, NC, US)
Source: Self-asserted source
Edgar Peña-Galo

Study of prevalence of functional gastrointestinal disease, according to the criteria of Rome III

Grant
Rome Foundation (NC, NC, US)
Source: Self-asserted source
Edgar Peña-Galo

Works (14)

Data from High Gastric Cancer Mortality and Years of Life Lost in Nicaragua: A Population-Based Study 1997 to 2012

2024-12-02 | Preprint
Contributors: Edgar M. Peña-Galo; Guillermo Palacios-Navarro; Javier Pastora-Membreño; Tatiana Torres-Herman; Dalton A. Norwood; Eleazar E. Montalvan-Sanchez; Timothy Beasley; Luis E. Bravo; Douglas R. Morgan
Source: check_circle
Crossref

High Gastric Cancer Mortality and Years of Life Lost in Nicaragua: A Population-Based Study 1997 to 2012

Cancer Epidemiology, Biomarkers & Prevention
2024-12-02 | Journal article
Contributors: Edgar M. Peña-Galo; Guillermo Palacios-Navarro; Javier Pastora-Membreño; Tatiana Torres-Herman; Dalton A. Norwood; Eleazar E. Montalvan-Sanchez; Timothy Beasley; Luis E. Bravo; Douglas R. Morgan
Source: check_circle
Crossref

Supplementary Figure S1 from High Gastric Cancer Mortality and Years of Life Lost in Nicaragua: A Population-Based Study 1997 to 2012

2024-12-02 | Preprint
Contributors: Edgar M. Peña-Galo; Guillermo Palacios-Navarro; Javier Pastora-Membreño; Tatiana Torres-Herman; Dalton A. Norwood; Eleazar E. Montalvan-Sanchez; Timothy Beasley; Luis E. Bravo; Douglas R. Morgan
Source: check_circle
Crossref

Supplementary Table S1 from High Gastric Cancer Mortality and Years of Life Lost in Nicaragua: A Population-Based Study 1997 to 2012

2024-12-02 | Preprint
Contributors: Edgar M. Peña-Galo; Guillermo Palacios-Navarro; Javier Pastora-Membreño; Tatiana Torres-Herman; Dalton A. Norwood; Eleazar E. Montalvan-Sanchez; Timothy Beasley; Luis E. Bravo; Douglas R. Morgan
Source: check_circle
Crossref

Supplementary Table S2 from High Gastric Cancer Mortality and Years of Life Lost in Nicaragua: A Population-Based Study 1997 to 2012

2024-12-02 | Preprint
Contributors: Edgar M. Peña-Galo; Guillermo Palacios-Navarro; Javier Pastora-Membreño; Tatiana Torres-Herman; Dalton A. Norwood; Eleazar E. Montalvan-Sanchez; Timothy Beasley; Luis E. Bravo; Douglas R. Morgan
Source: check_circle
Crossref

Supplementary Table S3 from High Gastric Cancer Mortality and Years of Life Lost in Nicaragua: A Population-Based Study 1997 to 2012

2024-12-02 | Preprint
Contributors: Edgar M. Peña-Galo; Guillermo Palacios-Navarro; Javier Pastora-Membreño; Tatiana Torres-Herman; Dalton A. Norwood; Eleazar E. Montalvan-Sanchez; Timothy Beasley; Luis E. Bravo; Douglas R. Morgan
Source: check_circle
Crossref

Enduring association between irritable bowel syndrome and war trauma during the Nicaragua civil war period: A population-based study.

World journal of gastroenterology
2023-12-01 | Journal article
Contributors: Peña-Galo EM; Wurzelmann D; Alcedo J; Peña R; Cortes L; Morgan D
Source: Self-asserted source
Edgar Peña-Galo

The Validity of the Invasive Tests for Helicobacter Pylori Diagnosis is Unequally Affected by the Consumption of Antibiotics or Pump Inhibitors. Test Performance under Real-World Conditions.

Journal of gastrointestinal and liver diseases : JGLD
2021-06-18 | Journal article
Contributors: Alcedo J; Casas D; Gotor J; Miguel Lafuente; Llorente M; Sanz-Segura P; Monzón R; Hörndler C; Peña-Galo EM
Source: Self-asserted source
Edgar Peña-Galo

[Evaluation of social distancing measures on the transmissibility of COVID-19 in rural areas. Retrospective logitudinal study of posible cases].

Semergen
2021-03-08 | Journal article
Contributors: Peña-Galo E; Turón-Alcaine JM; Gracia-Carrasco E; Alcedo-González J
Source: Self-asserted source
Edgar Peña-Galo

Socioeconomic and demographic factors associated with failure in <i>Helicobacter pylori</i> eradication using the standard triple therapy.

Gastroenterology and hepatology from bed to bench
2021-01-01 | Journal article
Contributors: Peña-Galo E; Gotor J; Harb Y; Alonso M; Alcedo J
Source: Self-asserted source
Edgar Peña-Galo

Long-term results with lanreotide in patients with recurrent gastrointestinal angiodysplasias bleeding or obscure gastrointestinal bleeding. Benefits in efficacy and procedures consumption

Scandinavian Journal of Gastroenterology
2018-12-02 | Journal article
Part of ISSN: 0036-5521
Part of ISSN: 1502-7708
Source: Self-asserted source
Edgar Peña-Galo

A Population-Based Study of Prevalence and Risk Factors of Chronic Kidney Disease in León, Nicaragua

Canadian Journal of Kidney Health and Disease
2015-08-18 | Journal article
Part of ISSN: 2054-3581
Part of ISSN: 2054-3581
Source: Self-asserted source
Edgar Peña-Galo

Risk of Recurrent Helicobacter pylori Infection 1 Year After Initial Eradication Therapy in 7 Latin American Communities

JAMA
2013-02-13 | Journal article
Part of ISSN: 0098-7484
Source: Self-asserted source
Edgar Peña-Galo

14-day triple, 5-day concomitant, and 10-day sequential therapies for Helicobacter pylori infection in seven Latin American sites: a randomised trial

The Lancet
2011-08 | Journal article
Part of ISSN: 0140-6736
Source: Self-asserted source
Edgar Peña-Galo